Safety and Efficacy of Ex Vivo Expanded Healthy Donor-Derived Double Negative T Cells for the Treatment of AML Relapsed after Allogeneic Stem Cell Transplantation: A First in-Human Phase I/IIa Clinical Trial

被引：11
|
作者：
Baolin, Tang
Lee, Jongbok
Cheng, Siqi
Yao, Wen
Wang, Dongyao
Tu, Meijuan
Xiang, Zhiqiang
Geng, Liangquan
Wang, Mingxia
Qiang, Ping
Teng, Pingping
Sun, Guangyu
Pan, Tianzhong
Liu, Huilan
Yang, Liming
Sun, Zimin
Zhang, Li
Zhu, Xiaoyu
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141505
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Treatment of Crohn's-Related Rectovaginal Fistula With Allogeneic Expanded-Adipose Derived Stem Cells: A Phase I-IIa Clinical Trial
    Garcia-Arranz, Mariano
    Herreros, Maria Dolores
    Gonzalez-Gomez, Carolina
    de la Quintana, Paloma
    Guadalajara, Hector
    Georgiev-Hristov, Tihomir
    Trebol, Jacobo
    Garcia-Olmo, Damian
    STEM CELLS TRANSLATIONAL MEDICINE, 2016, 5 (11) : 1441 - 1446
  • [22] Adoptive transfer of CMV- and EBV- specific peptide-stimulated T cells after allogeneic stem cell transplantation: A Phase I/IIa clinical trial
    Aigner, Michael
    Gary, Regina
    Moosmann, Andreas
    Maas, Stefanie
    Strobl, Julian
    Zimmermann, Robert
    Zingsem, Jurgen
    Kremer, Anita
    Mackensen, Andreas
    Gerbitz, Armin
    CANCER RESEARCH, 2017, 77
  • [23] Safety and Efficacy of Donor-Derived Virus Specific Cytotoxic T Lymphocytes(CTL) Administered in Treatment for CMV/EBV Infections after Allogenetic Stem Cell Transplantation
    Wang, Jingbo
    Huang, Xiaojun
    Hu, Ying
    Xue, Song
    Cheng, Haoyu
    Yin, Yuming
    Zhang, Weijie
    Gu, Jiangying
    He, Junbao
    Yang, Fan
    BLOOD, 2016, 128 (22)
  • [24] Allogeneic Donor-Derived Myeloid Antigen Directed CAR-T Cells - for Relapsed/Refractory Acute Myeloid Leukemia in Children after Allogeneic Hematopoietic Stem Cell Transplantation: Report of Three Cases
    Shelikhova, Larisa
    Rakhteenko, Arina
    Molostova, Olga
    Kurnikova, Elena
    Ukrainskaya, V
    Muzalevsky, Yakov
    Pershin, Dmitry
    Popov, Alexander
    Kulakovskaya, Elena
    Baidildina, Dina
    Stepanov, Alexey
    Osipova, Elena
    Novichkova, Galina
    Maschan, Alexey
    Maschan, Michael
    BLOOD, 2022, 140 : 4600 - 4601
  • [25] Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/II Clinical Trial in Progress
    Hagiwara, Shotaro
    Wang, Yan-Hua
    Kobayashi, Hirohito
    Kato, Yutaka
    Tanaka, Norina
    Iizuka, Yuki
    Watanabe, Aya
    Ishiyama, Midori
    Shinohara, Akihito
    Kazama, Hiroshi
    Yoshinaga, Kentaro
    Shiseki, Masayuki
    Kanno, Hitoshi
    Tanaka, Junji
    BLOOD, 2019, 134
  • [26] Phase I/II clinical trial demonstrates feasibility, safety and effectivity of CMV-pp65-specific donor T-cells for the treatment of refractory CMV reactivation after allogeneic stem cell transplantation
    Jedema, Inge
    van Balen, Peter
    Halkes, Constantijn J. M.
    van Egmond, Esther H. M.
    van Liempt, Ellis A. G.
    Veld, S. A. J.
    Hoogstraten, C.
    Meij, Pauline
    Kersting, Sabina
    Zwaginga, Jaap Jan
    Rauser, Georg
    Assenmacher, Mario
    Falkenburg, J. H. Frederik
    BONE MARROW TRANSPLANTATION, 2018, 53 : 45 - 45
  • [27] A Phase I Clinical Trial Testing the Safety of IL-21-Expanded, Universally Alloreactive Donor-Derived Natural Killer Cells for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Vasu, Sumithira
    Sharma, Nidhi
    Walker, Alison R.
    Wall, Sarah A.
    Blachly, James S.
    Behbehani, Greg K.
    Choe, Hannah
    Thakkar, Aarohi
    Nakkula, Robin
    Troy, Ella
    Szuminski, Nicole
    de Lima, Marcos J. G.
    O'Donnell, Lynn
    Lee, Dean Anthony
    BLOOD, 2021, 138
  • [28] Updated efficacy and safety report of a phase I trial of donor-derived CD7 CAR T cells for T-cell acute lymphoblastic leukemia.
    Pan, Jing
    Tan, Yue
    Wang, Guoling
    Deng, Biping
    Ling, Zhuojun
    Song, Weiliang
    Duan, Jiajia
    Xu, Jinlong
    Wang, Zelin
    Feng, Xiaoming
    Chang, Alex H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [29] Phase 1/2 Study of Nexi-001 Donor-Derived Multi-Antigen Specific CD8+T Cells for the Treatment of Relapsed Acute Myeloid Leukemia (AML) after Allogeneic Hematopoietic Transplantation
    Al Malki, Monzr M.
    Vasu, Sumithira
    Modi, Dipenkumar
    Perales, Miguel-Angel
    Ghoda, Lucy Y.
    Bui, Donna
    Edavana, Vineetha
    Lu, Emily
    Kim, Sojung
    Suarez, Lauren
    Oelke, Mathias
    Bednarik, Daniel
    Knight, Robert D.
    Varela, Juan C.
    BLOOD, 2021, 138
  • [30] Development of adult T-cell leukemia in donor-derived human T-cell leukemia virus type I-infected T cells after allogeneic bone marrow transplantation
    H Tamaki
    Y Taniguchi
    A Kikuchi
    T Yamagami
    T Soma
    M Matsuoka
    Leukemia, 2007, 21 : 1594 - 1596
12345